Case-control study of severe life threatening asthma (SLTA) in adults: Demographics, health care, and management of the acute attack

Thorax

Volumn 55, Issue 12, 2000, Pages 1007-1015

  Kolbe, J ^a,b   Fergusson, W ^a   Vamos, M ^c   Garrett, J ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Acute attack; Health care; Life threatening asthma; Socioeconomics

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CROMOGLYCATE DISODIUM; THEOPHYLLINE;

ADOLESCENT; ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FEMALE; HEALTH ECONOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SCORING SYSTEM;

ACUTE DISEASE; ADOLESCENT; ADULT; ASTHMA; CASE-CONTROL STUDIES; DELIVERY OF HEALTH CARE; DEMOGRAPHY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; QUALITY OF HEALTH CARE; QUESTIONNAIRES; RECURRENCE; RISK FACTORS; SELF CARE; STATUS ASTHMATICUS;

EID: 0033667196     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.12.1007     Document Type: Article

References (60)

1. Demographic characteristics of patients with severe life-threatening asthma: Comparison with asthma deaths
2. Long-term prognosis of near fatal asthma
3. Risk of fatal and nearfatal asthma in relation in relation to inhaled corticosteroid use
4. Risk of severe life-threatening asthma and β agonist type an example of confounding by severity
5. The association between asthma drugs and severe life-threatening attacks
6. A case-control study of deaths from asthma
7. The costs of asthma
8. Use of near-fatal asthma for investigating asthma deaths
9. Asthma mortality in New Zealand: A review with more policy implications
10. Asthma mortality: A review of recent experience in New Zealand
11. Influences on trends in asthma morbidity and mortality: The New Zealand experience
12. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: What lessons have been learned?
13. Identification of the high risk asthmatic patient. Experience with 39 patients undergoing ventilation for status asthmatics
14. Death from asthma in two regions of England
15. Asthma deaths in Cardiff 1963-74: 90 Deaths outside hospital
16. Circumstances surrounding the deaths of children due to asthma. A case-control study
17. Risk factors for death in patients admitted to hospital with asthma: A follow-up study
18. Socio-economic disadvantage, quality of medical care and admission for acute severe asthma
19. Differential influences on asthma self-management knowledge and self-management behaviour in acute severe asthma
20. Determinants of management errors in acute severe asthma
21. Types of epidemiologic study
22. The self-reported prevalence of asthma symptoms amongst adult New Zealanders
23. Questionnaire assessment of patients attitudes and beliefs about asthma
24. Cultural issues facing medical research in New Zealand: Short report of an asthma pilot study
25. Assessment of practical knowledge of self-management of acute asthma
26. Occupational asthma in a national disability survey
27. Asthma management plan
28. Guidelines for the management of asthma in adults. I. Chronic asthma
29. Guidelines for the management of asthma in adults. II Acute severe asthma
30. Rapid onset asthma: A severe but uncommon manifestation
31. Case-control study of severe life-threatening asthma (SLTA) in adults: Psychological factors
32. Identification of the high-risk asthmatic patient
33. A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals 1971
34. Asthma mortality in Birmingham 1975-7: 53 Deaths
35. Sudden asphyxic asthma: A distinct entity?
36. Asthma mortality in New Zealand: A two-year national study
37. A district confidential enquiry into deaths due to asthma
38. Near-fatal asthma in South Auckland: Descriptive features and medication use
39. Risk factors for near-fatal asthma. A case-control study in hospitalised patients with asthma
40. Health service accessibility and deaths from asthma in 401 local authority districts in England and Wales, 1988-92
41. The relationship between social and economic deprivation and asthma morbidity/mortality in New Zealand
42. Patient and physician characteristics influencing medical decisions in asthma
43. Education, action plans, psychological issues and adherence
44. Emergency room care of asthmatics: A comparison between Auckland and Toronto
45. Characteristics of patients admitted to hospital with chronic obstructive pulmonary disease
46. Placebo-controlled immunopathologic study for four months of inhaled corticosteroids in asthma
47. The relationship between the inflammatory infiltrate in bronchial biopsies and clinical severity of asthma in patients treated with inhaled steroids
48. 2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma; a randomised, double-blind parallelgroup controlled trial
49. Reduction of inflammatory cell recruitment by glucocorticoids; cytokines as primary targets
50. Effect of therapy on bronchial hyperresponsiveness in the long-term management of asthma
51. Effect of long-term treatment with inhaled corticosteroids and beta agonists on bronchial responsiveness in asthmatic children
52. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics
53. 2 agonist terbutaline with an inhaled steroid in newly detected asthma
54. Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma
55. Inhaled steroids and the risk of hospitalisation for asthma
56. Prescribed drug therapy and near-fatal asthma
57. 2 agonists and the risk of death and near death from asthma
58. Patient and physician characteristics influencing medical decisions in asthma
59. Panic-fear in asthma. Symptomatology as an index of signal anxiety and personality as an index of ego resources
60. Medical outcome in asthmatic patient: Effects of airways hyperreactivity and symptom-focussed anxiety